Hypnonorm (Zolpidem Tartrate)

Zolpidem is indicated for the treatment of insomnia, a sleep‑wake disorder.

• Insomnia: helps adults fall asleep faster and stay asleep through the night.
• Sleep onset insomnia: reduces the time needed to achieve sleep after bedtime.
• Sleep maintenance insomnia: decreases nighttime awakenings and improves overall sleep duration.

• Zolpidem acts as a positive allosteric modulator at the GABAA receptor complex, preferentially binding to receptors that contain the α1 subunit. This enhances the inhibitory effect of GABA, increasing chloride influx and hyperpolarizing neuronal membranes, which leads to sedation and facilitates the initiation of sleep without the broader receptor activity seen with benzodiazepines.

Common side effects are generally mild and transient.

Common Side Effects

• Drowsiness
• Dizziness
• Headache
• Nausea
• Dry mouth
• Unpleasant taste

Serious or Rare Side Effects

• Complex sleep behaviors (e.g., sleepwalking, sleep‑driving)
• Allergic reactions such as rash or angioedema
• Mood changes including depression or suicidal thoughts
• Hallucinations or psychotic episodes
• Respiratory depression, especially when combined with other CNS depressants
• Anaphylaxis (rare)

Before prescribing Hypnonorm, clinicians should evaluate the patient’s sleep disorder and overall health status.

• Assess sleep pattern: confirm diagnosis of insomnia before initiating therapy.
• Avoid CNS depressants: do not combine with alcohol, opioids, or other sedatives.
• Use lowest effective dose: start with the minimal dose required for therapeutic effect.
• Monitor for complex sleep behaviors: educate patients about unusual activities during sleep.
• Caution in hepatic impairment: dose adjustment may be needed.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Zolpidem may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Alcohol: additive sedation and increased risk of respiratory depression.
• Opioids: heightened central nervous system depression.
• Benzodiazepines or barbiturates: excessive sedation and impaired psychomotor function.
• Rifampin: induces metabolism, reducing zolpidem plasma levels.
• MAO inhibitors: may amplify hypnotic effects.

Moderate Interactions (Monitor Closely)

• SSRIs (e.g., fluoxetine, sertraline): increased risk of abnormal sleep behaviors.
• Antihistamines: additive drowsiness.
• CYP3A4 inhibitors (e.g., ketoconazole): may raise zolpidem concentrations, requiring dose review.